Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
about
Interventions for hirsutism (excluding laser and photoepilation therapy alone)Cyproterone acetate for hirsutismNutritional factors and hair loss.Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.Hirsutism: an evidence-based treatment update.Anti-androgens for the treatment of hirsutism.Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.Combined oral contraceptives in the treatment of polycystic ovary syndrome.Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndromeEpidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.Treatment of androgen excess in females: yesterday, today and tomorrow.Diane 35 and spironolactone combination in the treatment of hirsutism.A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.Androgens and Therapeutic Aspects of Antiandrogens in Women
P2860
Q24186393-9652D1A6-6628-46C7-9136-F659CAF555FFQ24247652-5EB67754-1AAA-465D-A9AF-E207BFE61AEDQ34145481-0D56FE1A-7219-4A08-B6AA-0E4351A9764FQ34406529-92F74C47-9D50-4888-ABEE-A81826C6A4DFQ34422575-BDCF2C52-C13B-4775-B23D-DDC6877A40CCQ34544658-B8135D27-0E86-4D4D-ADE5-68EBF1C2A2D1Q35927890-C50A6869-51A6-47AE-A35E-2BD0E9935885Q36080057-A8845C74-AEDF-46D0-ADF4-B543DEFE529FQ36823529-023D88D7-D135-41F1-B270-104D985C83FEQ37953819-28D4BAC4-E4E0-4095-A8F7-0B17F550EFDDQ38817439-F96E4975-143D-49BC-A5D3-55A77D1B978DQ39224740-AA816B4C-F1A5-4276-99EE-B03B2F18E685Q40869010-D297F80D-8C8A-4607-A825-6E141A6AC71DQ43622812-4877D80D-89E3-4F64-ACC6-BA2C3F780860Q44086641-4143D1A6-3C89-43DB-891D-4DEE9AAFBAF7Q45089948-B57ACE38-8A19-460B-AFE0-CF373F42B0E1Q47706800-3296F406-C253-467F-B132-F88C981BE060Q55954238-94F2FDE0-4741-418E-BF59-55B5E43652CD
P2860
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@ast
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@en
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@nl
type
label
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@ast
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@en
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@nl
prefLabel
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@ast
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@en
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@nl
P2093
P2860
P1476
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
@en
P2093
Wojnarowska F
P2860
P356
10.1111/J.1365-2265.1991.TB03489.X
P577
1991-07-01T00:00:00Z